Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoidosis × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 16 Spondylitis, Ankylosing 5 Psoriasis 4 Crohn Disease 3 Inflammatory Bowel Diseases 2 Colitis, Ulcerative 2 Uveal Melanoma 1 Thyroid Carcinoma, Anaplastic 1 Spondylarthritis 1 Sarcoidosis 1 Plaque Psoriasis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Melanoma 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammation 1 Infections 1 Healthy Adult Male 1 Healthy 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Autoimmune Diseases 1 Arthritis, Psoriatic 1

Interventions

Suction 1 Needles 1 Lidocaine 1 Conscious Sedation 1 Bronchoalveolar Lavage 1 Blood Pressure 1 Biopsy, Fine-Needle 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00311246 2020-08-25

Trial of Adalimumab in Progressive Sarcoidosis

University of Chicago

Phase 2 Terminated

11 enrolled 8 charts

Sarcoidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡